Skip to content
Screener

Bio-Techne TECH Intangibles (Net)

Intangibles (Net) at other companies

Danaher logo
DanaherDHR
$21.36B+14.6%
Bruker logo
BrukerBRKR
$867.8M-10.5%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$59.91M+294%
Revvity logo
RevvityRVTY
$2.31B-10.3%
Agilent Technologies logo
Agilent TechnologiesA
$407M-17.8%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$166.8M+73.8%

Segments

By geography

See full
United States And Canada$443.74M
Europe$63.14M

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.22B+43.5%
Enterprise value$11.3B+39.5%
P/E74.9×+16.9×
P/S9.3×+2.9×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemMarch 31, 2026 / (unaudited)June 30, 2025
Property and equipment, net232,990245,719
Right-of-use assets68,31673,399
Goodwill977,800980,935
Intangible assets, net319,074365,599
Other assets264,371283,916
Total assets$2,550,601$2,557,868
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's intangibles (net)?
Bio-Techne (TECH) reported intangibles (net) of $319.07M in Q1 2026.
How has Bio-Techne's intangibles (net) changed year-over-year?
Bio-Techne's intangibles (net) decreased by 28.1% year-over-year, from $443.7M to $319.07M.
What is the long-term trend for Bio-Techne's intangibles (net)?
Over 4 years (2021 to 2025), Bio-Techne's intangibles (net) has grown at a -12.2% compound annual growth rate (CAGR), from $615.97M to $365.6M.
What does intangibles (net) mean?
Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.

Ask your AI about Bio-Techne's intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude